Heparin sodium is a naturally occurring anticoagulant and one of the most essential medicines in global healthcare. As an unfractionated heparin (UFH) extracted from mammalian tissues, it is critical for the prevention and treatment of thrombosis, maintaining catheter patency, and numerous surgical and dialysis applications. With global trade valued at approximately $3.53 billion in 2024, understanding the buyer landscape is essential for API suppliers, manufacturers, and distributors seeking to navigate this highly regulated and concentrated market. Understanding the Heparin Sodium Market Landscape The global heparin supply chain is characterized by significant geographic concentration in both production and consumption. China, the United States, and Singapore dominate exports, while France, the United…